Search Results - "Rancoule, Chloe"

Refine Results
  1. 1

    Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? by Chargari, Cyrus, Goodman, Karyn A., Diallo, Ibrahima, Guy, Jean-Baptiste, Rancoule, Chloe, Cosset, Jean-Marc, Deutsch, Eric, Magne, Nicolas

    Published in Cancer and metastasis reviews (01-06-2016)
    “…In the era of modern radiation therapy, the compromise between the reductions in deterministic radiation-induced toxicities through highly conformal devices…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies by He, Ming Yuan, Rancoule, Chloé, Rehailia-Blanchard, Amel, Espenel, Sophie, Trone, Jane-Chloé, Bernichon, Emilie, Guillaume, Elodie, Vallard, Alexis, Magné, Nicolas

    Published in Critical reviews in oncology/hematology (01-11-2018)
    “…Triple-negative breast cancer (TNBC) (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is viewed as an aggressive subgroup of…”
    Get full text
    Journal Article
  4. 4

    Nanoparticles in radiation oncology: from bench-side to bedside by Rancoule, Chloé, Magne, Nicolas, Vallard, Alexis, Guy, Jean-Baptiste, Rodriguez-Lafrasse, Claire, Deutsch, Eric, Chargari, Cyrus

    Published in Cancer letters (01-06-2016)
    “…Highlights • NP can be used as radio-sensitizers (high Z physical mechanism + biological pathways). • NP can be used as drug vectors in radiochemotherapy. • NP…”
    Get full text
    Journal Article
  5. 5

    Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis by Rancoule, Chloé, Dusaulcy, Rodolphe, Tréguer, Karine, Grès, Sandra, Attané, Camille, Saulnier-Blache, Jean Sébastien

    Published in Biochimie (01-01-2014)
    “…Autotaxin (ATX) is a secreted lysophospholipase D involved in synthesis of lysophosphatidic acid (LPA), a phospholipid growth factor acting via specific…”
    Get full text
    Journal Article
  6. 6

    Biological aspects of chondrosarcoma: Leaps and hurdles by Mery, Benoîte, Espenel, Sophie, Guy, Jean-Baptiste, Rancoule, Chloé, Vallard, Alexis, Aloy, Marie-Thérèse, Rodriguez-Lafrasse, Claire, Magné, Nicolas

    Published in Critical reviews in oncology/hematology (01-06-2018)
    “…Chondrosarcomas are characterized by their chemo- and radioresistance leading to a therapeutic surgical approach which remains the only available treatment…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid by Dusaulcy, Rodolphe, Rancoule, Chloé, Grès, Sandra, Wanecq, Estelle, Colom, André, Guigné, Charlotte, van Meeteren, Laurens A., Moolenaar, Wouter H., Valet, Philippe, Saulnier-Blache, Jean Sébastien

    Published in Journal of lipid research (01-06-2011)
    “…Autotaxin (ATX) is a secreted lysophospholipase D that generates the lipid mediator lysophosphatidic acid (LPA). ATX is secreted by adipose tissue and its…”
    Get full text
    Journal Article
  9. 9

    Melanoma: last call for radiotherapy by Espenel, Sophie, Vallard, Alexis, Rancoule, Chloé, Garcia, Max-Adrien, Guy, Jean-Baptiste, Chargari, Cyrus, Deutsch, Eric, Magné, Nicolas

    Published in Critical reviews in oncology/hematology (01-02-2017)
    “…Highlights • Indications of radiotherapy are currently reduced in melanoma. • Hadrontherapy and high doses radiotherapy might be interesting techniques in…”
    Get full text
    Journal Article
  10. 10

    Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view by Vallard, Alexis, Magné, Nicolas, Guy, Jean-Baptiste, Espenel, Sophie, Rancoule, Chloé, Diao, Peng, Deutsch, Eric, Rivera, Sofia, Chargari, Cyrus

    Published in British journal of radiology (01-05-2019)
    “…Breast conserving therapy (BCT) is currently a recognized alternative to mastectomy for early BC patients. However, the therapeutic index of BCT was considered…”
    Get full text
    Journal Article
  11. 11

    Effects of dietary eicosapentaenoic acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle by Bertrand, Chantal, Pignalosa, Angelica, Wanecq, Estelle, Rancoule, Chloé, Batut, Aurélie, Deleruyelle, Simon, Lionetti, Lillà, Valet, Philippe, Castan-Laurell, Isabelle

    Published in PloS one (07-11-2013)
    “…Various studies have shown that eicosapentaenoic acid (EPA) has beneficial effects on obesity and associated disorders. Apelin, the ligand of APJ receptor also…”
    Get full text
    Journal Article
  12. 12

    Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review by Langrand-Escure, Julien, Rivoirard, Romain, Oriol, Mathieu, Tinquaut, Fabien, Rancoule, Chloé, Chauvin, Frank, Magné, Nicolas, Bourmaud, Aurélie

    Published in PloS one (07-12-2017)
    “…Phase II clinical trials are a cornerstone of the development in experimental treatments They work as a "filter" for phase III trials confirmation…”
    Get full text
    Journal Article
  13. 13

    Optimize and refine therapeutic index in radiation therapy: overview of a century by Chargari, Cyrus, Magne, Nicolas, Guy, Jean-Baptiste, Rancoule, Chloé, Levy, Antonin, Goodman, Karyn A, Deutsch, Eric

    Published in Cancer treatment reviews (01-04-2016)
    “…Highlights • In 1936, the probability of reaching tumor control with radiotherapy was described.. • Concepts about modulate differential response between…”
    Get full text
    Journal Article
  14. 14

    50th anniversary of cisplatin by Rancoule, Chloé, Guy, Jean-Baptiste, Vallard, Alexis, Ben Mrad, Majed, Rehailia, Amel, Magné, Nicolas

    Published in Bulletin du cancer (01-02-2017)
    “…We have just celebrated the 50th anniversary of cisplatin cytotoxic potential discovery. It is time to take stock… and it seems mainly positive. This drug,…”
    Get more information
    Journal Article
  15. 15

    Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry by Guy, Jean-Baptiste, Bertoletti, Laurent, Magné, Nicolas, Rancoule, Chloé, Mahé, Isabelle, Font, Carme, Sanz, Oscar, Martín-Antorán, José Manuel, Pace, Federica, Vela, Jerónimo Ramón, Monreal, Manuel

    Published in Critical reviews in oncology/hematology (01-05-2017)
    “…Highlights • 13% Of patients with cancer-associated thrombosis received a radiotherapy treatment. • A higher rate of pulmonary embolism recurrence was observed…”
    Get full text
    Journal Article
  16. 16

    Impact of Radiation Therapy on Biological Parameters in Cancer Patients: Sub-analysis from the RIT Prospective Epidemiological Study by Magné, Nicolas, Daguenet, Elisabeth, Bouleftour, Wafa, Conraux, Laurine, Tinquaut, Fabien, Grangeon, Kevin, Moreno-Acosta, Pablo, Suchaud, Jean-Philippe, Rancoule, Chloé, Guy, Jean-Baptiste

    Published in Cancer investigation (07-02-2023)
    “…Scarce data investigate the impact of radiotherapy (RT) on biology markers. An analysis of ancillary study of RIT (Radiation Impact on Thromboembolic events)…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Preclinical models in HNSCC: A comprehensive review by Méry, Benoite, Rancoule, Chloé, Guy, Jean-Baptiste, Espenel, Sophie, Wozny, Anne-Sophie, Battiston-Montagne, Priscilla, Ardail, Dominique, Beuve, Michael, Alphonse, Gersende, Rodriguez-Lafrasse, Claire, Magné, Nicolas

    Published in Oral oncology (01-02-2017)
    “…Highlights • Reliable experimental models are critically required in HNSCC. • Immortalized cell lines represent a valuable tool widely used in HNSCC research…”
    Get full text
    Journal Article
  19. 19

    Venous thromboembolism and radiation therapy: The final radiation‐induced thrombosis study analysis by Daguenet, Elisabeth, Maison, Mathilde, Tinquaut, Fabien, Giroux, Eric‐Alban, Bertoletti, Laurent, Suchaud, Jean‐Philippe, Rancoule, Chloé, Guy, Jean‐Baptiste, Magné, Nicolas

    Published in Cancer medicine (Malden, MA) (01-04-2022)
    “…Background Thromboembolic events frequently complicate the course of malignancy and represent a major cause of morbidity and mortality in cancer patients. In…”
    Get full text
    Journal Article
  20. 20